Healthcare / Medical DevicesUpdated 2026-05-10 22:07 UTC

TMCI stock hub

Treace Medical Concepts, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

TMCIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

129.9M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

TMCI

In the news

Latest news · TMCI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-66.9

P25 -106.6P50 -46.9P75 -3.1

ROIC-21.7

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All TMCI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001630627
Company name	Treace Medical Concepts, Inc.
Country	United States
Country code	US
Cusip	89455T109
Employees	450
Employees Change	-27%
Employees Change Percent	-5.66
Enterprise value	$147.4M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Medical Devices
IPO Date	2021-04-23
Isin	US89455T1097
Last refreshed	2026-05-10
Market cap	$129.9M
Market cap category	Micro-Cap
Price	$2.01
Price currency	USD
Rev Per Employee	460,706.67x
Sector	Healthcare
Sic	3841
Symbol	TMCI
Website	https://www.treace.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-47%
EV Sales Forward	0.7x
EV/Sales	0.71x
FCF yield	-19.99%
P/B ratio	1.69x
P/S ratio	0.63x
PS Forward	0.62x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-26.89%
EBITDA Margin	-23%
Gross margin	79.72%
Gross Profit	$165.3M
Gross Profit Growth	-2.31%
Gross Profit Growth Q	-10.71%
Gross Profit Growth3 Y	9.31%
Gross Profit Growth5 Y	26.31%
Net Income	$-61M
Net Income Growth Years	0%
Pretax Margin	-29.44%
Profit Margin	-29.44%
Profit Per Employee	$-135,647
ROA	-17.87
Roa5y	-14.58
ROCE	-37.26
ROE	-66.88
Roe5y	-50.57
ROIC	-21.69

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-72.11%
Cagr3y	-57.65%
Cagr5y	-42.71%
EPS Growth Years	0
FCF Growth Q	537.86%
OCF Growth Q	72.46%
Revenue Growth	-1.66x
Revenue Growth Q	-10.22x
Revenue Growth Years	6x
Revenue Growth3 Y	10.18x
Revenue Growth5 Y	26.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$1.06
Assets	$184.1M
Cash	$51.9M
Current Assets	$123.5M
Current Liabilities	$34.5M
Debt	$69.4M
Debt Equity	$0.9
Equity	$77.2M
Interest Coverage	-9.99
Liabilities	$106.9M
Long Term Assets	$60.6M
Long Term Liabilities	$72.4M
Net Cash	$-17.5M
Net Cash By Market Cap	$-13.49
Net Debt Equity	$0.23
Tangible Book Value	$57.5M
Tangible Book Value Per Share	$0.88
WACC	8.96

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.58
Inventory Turnover	1.13
Net Working Capital	$37.1M
Quick ratio	2.38
Working Capital	$89M
Working Capital Turnover	$2.02

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-2.28%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-72.08%
200-day SMA	3.85
3Y total return	-92.41%
50-day SMA	1.62
50-day SMA vs 200-day SMA	50under200
5Y total return	-93.83%
All Time High	37.17
All Time High Change	-94.59%
All Time High Date	2021-06-14
All Time Low	1.17
All Time Low Change	71.79%
All Time Low Date	2026-03-30
ATR	0.17
Beta	1.11
Beta1y	3.39
Beta2y	2.56
Ch YTD	-17.96
High	2.23
High52	7.78
High52 Date	2025-08-22
High52ch	-74.16%
Low	1.88
Low52	1.17
Low52 Date	2026-03-30
Low52ch	71.8%
Ma50ch	23.77%
Premarket Change Percent	4.69
Premarket Price	$2.01
Premarket Volume	33,597
Price vs 200-day SMA	-47.83%
RSI	59.76
RSI Monthly	33.43
RSI Weekly	38.96
Sharpe ratio	-1.34x
Sortino ratio	-1.66
Total Return	-2.28%
Tr YTD	-17.96
Tr1m	50%
Tr1w	8.07%
Tr3m	-11.06%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	6
Analyst Count Top	2
Analyst Price Target Top	$5
Analyst Ratings	Hold
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.31
Earnings Revenue Estimate	46,028,000x
Earnings Revenue Estimate Growth	-12.44x
Operating Income	$-55.7M
Operating margin	-26.89
Price target	$4.77
Price Target Change	$137
Price Target Change Top	$149

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	48,042,470%
Float Percent	74.35%
Net Borrowing	3,166,000
Shares Insiders	25.65%
Shares Institutions	44.6%
Shares Out	64,618,923
Shares Qo Q	1.15%
Shares Yo Y	2.28%
Short Float	10.05%
Short Ratio	4.85
Short Shares	7.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-59.1M
Average Volume	499,498.45x
Bv Per Share	1.19
CAPEX	$-13M
Ch1m	50
Ch1w	8.07
Ch1y	-72.08
Ch3m	-11.06
Ch3y	-92.41
Ch5y	-93.83
Ch6m	-54.98
Change	4.69%
Change From Open	-4.74
Close	1.92
Days Gap	9.9
Depreciation Amortization	8,061,000
Dollar Volume	1,535,340.5
Earnings Date	2026-05-08
Earnings Time	bmo
EBIT	$-55.7M
EBITDA	$-47.7M
EPS	$-0.96
F Score	2
FCF	$-26M
FCF EV Yield	-17.61x
FCF Per Share	$-0.4
Financing CF	1,771,000
Fiscal Year End	December
Founded	2,014
Goodwill	12,815,000
Investing CF	7,329,000
Ipr	-88.18
Iprfo	-91.8
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-08
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-27
Ma150	2.91
Ma150ch	-30.81%
Ma20	1.93
Ma20ch	4.42%
Net CF	-3,828,000
Next Earnings Date	2026-08-06
Open	2.11
Optionable	Yes
Position In Range	38.03
Ppne	39,434,000
Pre Close	1.92
Price Date	2026-05-08
Ptbv Ratio	2.26
Relative Volume	1.53x
Revenue	207,318,000x
SBC By Revenue	16x
Share Based Comp	33,164,000
Tr6m	-54.98%
Us State	Florida
Volume	763,851

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does TMCI pay a dividend?

Capital-return profile for this ticker.

Performance

TMCI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns TMCI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+44.6%

Float: +74.3% of shares outstanding

Insider ownership

+25.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

TMCI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

59.8

Neutral momentum band

Price vs 200-day MA

-47.8%

50/200-day relationship not available

Beta (5Y)

1.11

Moves roughly with the market

Sharpe ratio

-1.34

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About TMCI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current TMCI stock rating?

Treace Medical Concepts, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full TMCI analysis?

The full report lives at /stocks/TMCI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for TMCI?

The latest report frames TMCI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the TMCI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.